Recorded live on Thursday, May 20, 2021 • Hosted by AST's Thoracic and Critical Care Community of Practice (TCC COP)
"Consensus Conference on Heart-Kidney"
(Am J Transplant. 2021 Feb 2. doi: 10.1111/ajt.16512. Online ahead of print.)
In this article:
Simultaneous heart-kidney transplant (sHK) has enabled the successful transplantation of patients with end-stage heart disease and concomitant kidney disease, with non-inferior outcomes to heart transplant (HT) alone. The decision for sHK is challenged by difficulties in differentiating those patients with a significant component of reversible kidney injury due to cardiorenal syndrome who may recover kidney function after HT, from those with intrinsic advanced kidney disease who would benefit most from sHK. A consensus conference on sHK took place on June 1, 2019 in Boston, Massachusetts [and] represented a collaborative effort by experts in cardiothoracic and kidney transplantation from centers across the United States to explore the development of guidelines for the interdisciplinary criteria for kidney transplantation in the sHK candidate, to evaluate the current allocation of kidneys to follow the heart for sHK, and to recommend standardized care for the management of sHK recipients... The findings and consensus statements are presented.
- Jon Kobashigawa, MD, FAST • Cedars-Sinai Medical Center, Los Angeles, CA
- Darshana Dadhania, MD, MS, FAST • Weill Cornell Medicine, New York, NY
- Xingxing Shelley Cheng, MD • Stanford University, Stanford, CA
- Maryjane Farr, MD, MSc, FACC, FAST • Columbia University Medical Center, New York, NY